查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433352

全球神经血栓切除术设备市场 2023-2030

Global Neurothrombectomy Devices Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 250 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030 年），全球神经血栓切除设备市场将以 7.3% 的CAGR成长。该市场的成长归因于全球急性缺血性中风发病率的增加、不健康生活方式的增加以及人们对该疾病的认识不断提高，这些都推动了市场的成长。根据世界中风组织 2022 年情况说明书，所有年龄层的缺血性中风盛行率为 7,630,803 人。每年每 10 万人的粗率为 94.5，每年每 10 万人的年龄调整率为 98.6。每年有超过 760 万例新缺血性中风。在全球范围内，超过 62.0% 的中风事件是缺血性中风。其中，每年超过11%的缺血性中风发生在15-49岁的人群中，超过58.0%的缺血性中风发生在70岁以下的人群中，45.0%的缺血性中风发生在男性中， 55.0% 的缺血性中风发生在男性。% 的缺血性中风发生在女性身上。此外，2022年11月，《老年人口统计：美国老化肖像》一文报道，有5,410万成年人，即美国人口的16.3%是老年人，其中包括65岁或以上的老年人。预计到 2040 年，老年人口将增至 22.0%，到 2060 年将增至 25.0%。

细分市场前景

全球神经血栓切除术设备市场根据产品和最终用户进行细分。根据产品，市场细分为血栓回收装置、抽吸装置和血管圈套器。此外，根据最终用户，市场分为医院和急诊诊所。在最终用户中，预计医院细分市场将在预测期内占据最大的市场份额。该细分市场的大部分份额归功于较低的成本、较高的效率和可用性。

预计血栓回收设备细分市场将在全球神经血栓切除设备市场中占据相当大的份额

在这些产品中，凝块检索设备子细分市场预计将在预测期内成长。此细分市场的推动因素是 AIS 日益普及以及主要市场参与者推出的产品数量不断增加。它主要用于清除脑动脉中的血栓。此外，由于中风发病率不断上升，老年患者（55 岁至 65 岁）的血栓回收器使用量增加。因此，越来越多的针对性疾病病例正在推动细分市场的成长。此外，FDA 批准数量的增加正在加速该细分市场的成长。 2023 年 6 月，Innova Vascular, Inc. 的 Laguna Clot Retriever (TM) 系统和 Malibu Aspiration Catheter (TM) 系统获得美国食品和药物管理局 (FDA) 510(k) 批准，用于外周脉管系统。这两种新设备统称为拉古纳血栓切除系统。

区域展望

全球神经血栓切除设备市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本） 、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，亚太地区预计将在预测期内大幅成长。这是由于对神经血栓切除术设备的需求不断增长、老年人口不断增加、医疗保健支出不断增加以及心血管疾病 (CVD) 和心臟相关疾病的发病率不断增加。

北美地区全球神经血栓切除设备市场预计将以显着的CAGR成长

预计在预测期内，北美将在神经血栓切除术设备市场中占据显着份额。推动北美市场发展的重要因素包括神经血栓切除设备技术的不断进步、中风发病率的上升、老年人口的增加以及政府对监测设备的有利法规。根据美国人口普查局的数据，老年人口增加了5,090 万，从1920 年的490 万（占美国总人口的4.7%）增加到2020 年的5,580 万（占美国总人口的16.8%）。2020 年，大约每6 人中就有1 人患有老年痴呆症。美国的年龄在 65 岁及以上。 1920 年，这一比例还不到二十分之一。此外，未来对神经血栓切除装置和其他技术进步的需求可能会增加，以确保改善 CVD 预防和控制。根据美国心臟协会的数据，心血管疾病仍然是美国的首要死因，2020 年导致 928,741 人死亡。此外，心臟相关疾病数量的增加和技术进步正在进一步推动该地区的市场。 2020 年，在美国，冠状动脉心臟病 (CHD) 是美国 CVD 死亡的主要原因 (41.2%)，其次是中风 (17.3%)。

市场参与者展望

服务全球神经血栓切除设备市场的主要公司包括 Acandis GmbH、Medtronic plc、Penumbra, Inc. 和 Stryker Corp. 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2023 年 7 月，总部位于加州洛斯阿图斯的一家开发标靶联合疗法的临床阶段生物製药公司 RenovoRx, Inc. 与总部位于澳洲雪梨的临床阶段免疫肿瘤公司 Imugene Ltd 达成策略合作协议。研究合作旨在优化Imugene 溶瘤病毒疗法与RenovoRx 经动脉微灌注(TAMP) 治疗平台的交付，以治疗难以接近的肿瘤。作为合作的一部分，Imugene 和 RenovoRx 将研究利用 RenovoRx 的 TAMP 治疗平台管理 Imugene 的 CF33 溶瘤病毒技术的能力。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球神经血栓切除术设备市场的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Acandis GmbH
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Medtronic plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Penumbra, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Stryker Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 全球神经血栓切除术设备市场（按产品）
    • 血块回收装置
    • 抽吸装置
    • 血管圈套器
  • 全球神经血栓切除术设备市场（按最终用户）
    • 医院
    • 急诊诊所

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Abbott Laboratories
  • Acandis GmbH
  • ARGON MEDICAL
  • Boston Scientific Corp.,
  • Edwards Lifesciences Corp.,
  • INARI Medical
  • Johnson & Johnson Pvt Ltd
  • Koninklijke Philips N.V.
  • Microport Scientific Corp.,
  • Penumbra, Inc.
  • Phenox GmbH
  • Siemens Healthineers
  • Teleflex Inc.,
  • Terumo Corp.,
  • Vesalio, LLC
  • W.L. Gore & Associatess, Inc.
Product Code: OMR2028016

Global Neurothrombectomy Devices Market Size, Share & Trends Analysis Report by Product (Clot Retrievers Devices, Aspiration Devices, and Vascular Snares), and by End-User (Hospitals and Emergency Clinics), Forecast Period (2023-2030)

The global neurothrombectomy devices market is anticipated to grow at a CAGR of 7.3% during the forecast period (2023-2030). The growth of this market is attributed to the increasing incidences of acute ischemic stroke globally, rising adoption of unhealthy lifestyles and increasing awareness of the disorder among the population is fueling market growth. According to the World Stroke Organization Fact Sheet 2022, Prevalence for all Ischemic stroke for all ages were 7,630,803. The crude rate per 100,000 per year was 94.5, and Age-adjusted rate per 100,000, per year was 98.6. There are over 7.6 million new ischemic strokes each year. Globally, over 62.0% of all incident strokes are ischemic strokes. Of which, each year, over 11% of all ischemic strokes occur in people 15-49 years of age, over 58.0% of all ischemic strokes occur in people aged under 70 years, 45.0% of all ischemic strokes occur in men, and 55.0% of all ischemic strokes occur in women. In addition, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 or older. The senior population is expected to rise to 22.0% by 2040 and 25.0% by 2060.

Segmental Outlook

The global neurothrombectomy devices market is segmented based on product and end-user. Based on the product, the market is sub-segmented into clot retrievers devices, aspiration devices, and vascular snares. Further, based on end-user, the market is bifurcated into hospitals and emergency clinics. Among the end-user, the hospitals sub-segment is anticipated to hold the largest market share during the forecast period. The large share of this segment is credited to the lower costs, higher efficiency, and availability.

The Clot Retrievers Devices Sub-Segment is Anticipated to Hold a Considerable Share of the Global Neurothrombectomy Devices Market

Among the products, clot retrievers devices sub-segments expected to grow over the forecast period. The segment is driven by the owing to rising prevalence of AIS and an increasing number of product launches by key market players. It is majorly used for removing blood clots from the cerebral arteries. Furthermore, the use of clot retrievers has increased in elderly patients (aged 55 to 65) owing to growing incidence of stroke. Hence, growing cases of targeted disorder are driving segment growth. In addition, the growing number of FDA approvals is accelerating the segmental growth. In June 2023, Innova Vascular, Inc. received US Food and Drug Administration (FDA) 510(k) clearance for its Laguna Clot Retriever™ System and its Malibu Aspiration Catheter™ System for use in the peripheral vasculature. The two new devices are collectively known as the Laguna Thrombectomy System.

Regional Outlook

The global neurothrombectomy devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to grow considerably over the forecast period. This is owing to the growing demand for neurothrombectomy devices, increasing geriatric population, the rising healthcare expenditure, and increasing incidences of cardiovascular diseases (CVDs) and heart related conditions.

The North America Region is Expected to Grow at a Significant CAGR in the Global Neurothrombectomy Devices Market

North America is expected to hold a prominent share in the neurothrombectomy devices market during the forecast period. The significant factors fueling the North America market including growing technological advancements in neurothrombectomy devices, rising incidences of strokes, increasing geriatric population, and favorable government regulations regarding monitoring devices. According to the United States Census Bureau, the older population increased by 50.9 million, from 4.9 million (or 4.7% of the total US population) in 1920 to 55.8 million (16.8%) in 2020. In 2020, about 1 in 6 people in the US were age 65 and over. In 1920, this proportion was less than 1 in 20. In addition, the demand for neurothrombectomy devices, and other technological advancements to ensure improved CVD prevention and control is likely to rise in the future. According to the American Heart Association, CVDs remains as the leading cause of death in the US, accounted for 928,741 deaths in the year 2020. Additionally, the increasing number of heart-related disorders and technological advancements are further driving the market in the region. In 2020 in the US, coronary heart disease (CHD) was the leading cause (41.2%) of deaths attributable to CVD in the US, followed by stroke (17.3%).

Market Players Outlook

The major companies serving the global neurothrombectomy devices market includes Acandis GmbH, Medtronic plc, Penumbra, Inc., and Stryker Corp., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2023, RenovoRx, Inc., a Los Altos, California-based clinical-stage biopharmaceutical company developing targeted combination therapies, and Imugene Ltd, a clinical-stage immuno-oncology company headquartered in Sydney, Australia, entered a strategic research collaboration to optimize the delivery of Imugene's oncolytic virus therapy with RenovoRx's trans arterial micro perfusion (TAMP) therapy platform for the treatment of difficult-to-access tumors. As part of the collaboration, Imugene and RenovoRx will investigate the ability to administer Imugene's CF33 oncolytic virus technology with RenovoRx's TAMP therapy platform.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global neurothrombectomy devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Acandis GmbH
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Medtronic plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Penumbra, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Stryker Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Neurothrombectomy Devices Market by Product
    • 4.1.1. Clot Retrievers Devices
    • 4.1.2. Aspiration Devices
    • 4.1.3. Vascular Snares
  • 4.2. Global Neurothrombectomy Devices Market by End-User
    • 4.2.1. Hospitals
    • 4.2.2. Emergency Clinics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Acandis GmbH
  • 6.3. ARGON MEDICAL
  • 6.4. Boston Scientific Corp.,
  • 6.5. Edwards Lifesciences Corp.,
  • 6.6. INARI Medical
  • 6.7. Johnson & Johnson Pvt Ltd
  • 6.8. Koninklijke Philips N.V.
  • 6.9. Microport Scientific Corp.,
  • 6.10. Penumbra, Inc.
  • 6.11. Phenox GmbH
  • 6.12. Siemens Healthineers
  • 6.13. Teleflex Inc.,
  • 6.14. Terumo Corp.,
  • 6.15. Vesalio, LLC
  • 6.16. W.L. Gore & Associatess, Inc.

LIST OF TABLES

  • 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL CLOT RETRIEVERS NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL ASPIRATION NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL VASCULAR SNARES NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 6. GLOBAL NEUROTHROMBECTOMY DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL NEUROTHROMBECTOMY DEVICES FOR EMERGENCY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. NORTH AMERICAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 12. EUROPEAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. EUROPEAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 14. EUROPEAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 15. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER,2022-2030 ($ MILLION)
  • 18. REST OF THE WORLD NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL CLOT RETRIEVERS NEUROTHROMBECTOMY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL ASPIRATION NEUROTHROMBECTOMY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL VASCULAR SNARES NEUROTHROMBECTOMY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
  • 6. GLOBAL NEUROTHROMBECTOMY DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NEUROTHROMBECTOMY DEVICES FOR EMERGENCY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. US NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 10. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. UK NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. REST OF EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)